Latest news
Can Vitrafy Life Sciences (ASX:VFY) Turn Healthcare Innovation Into Commercial Growth? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 00:30:00 GMTVFY:ASX Announcement - FY26 Appendix 4E and Annual Report - 04 Aug 2026 - Market IndexMarket Index · Tue, 04 Aug 2026 11:38:07 GMTVitrafy Life Sciences Ltd (ASX:VFY) (FY 2026) Earnings Call Highlights: 94. ... - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 07:00:25 GMTVitrafy Life Sciences Unveils FY2026 Annual Results Presentation Highlighting Biologics Infrastructure Development - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Submits Appendix 4G Confirming Corporate Governance Compliance for FY2026 - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Sets Cautious Tone in FY2026 Results Presentation - TipRanksTipRanks · Mon, 03 Aug 2026 23:21:21 GMTVFY: Revenue up 80%, net loss halved, and $32m raised to fund U.S. commercialisation and growth - TradingViewTradingView · Mon, 03 Aug 2026 22:47:29 GMTVFY: Strong revenue growth, major partnerships, and U.S. expansion position for FY27 scale - TradingViewTradingView · Mon, 03 Aug 2026 22:45:32 GMT